Final Results Of A Ctep Sponsored Phase I Study Of Alistertib In Combination With Bortezomib And Rituximab In Replapsed And Refractory Mantle Cell And Low Grade Non-Hodgkin LymphomaStefan Klaus Barta,Noah Kornblum,Bruce G. Raphael,Kenneth B. Hymes,Michael L. Grossbard,Tibor Moskovits,Elizabeth Handorf,Joseph Sparano,Richard Piekarz,Catherine DiefenbachBLOOD（2018）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
